Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis

Vaccine

Volumn 30, Issue 13, 2012, Pages 2282-2287

  Cui, Xia ^a   Lei, Tao ^a   Yang, Daoyu ^a   Hao, Pan ^a   Li, Bo ^a   Liu, Qun ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Immune mapped protein1; Immunity; Toxoplasma gondii; Toxoplasmosis; Vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PLASMID DNA; TOXOPLASMA GONDII IMMUNE MAPPED PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE CONSTRUCT; GENE INSERTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION; RECOMBINANT PLASMID; SEQUENCE ANALYSIS; SURVIVAL TIME; TACHYZOITE; TH1 CELL; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; CYTOKINES; FEMALE; HEK293 CELLS; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

EID: 84862797129     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.073     Document Type: Article

References (34)

1. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000, 30:1217-1258.
2. Petersen E., Pollak A., Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol 2001, 31:115-144.
3. Luft G.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992, 15:211-222.
4. Elsheikha H.M. Congenital toxoplasmosis: priorities for further health promotion action. Public Health 2008, 122:335-353.
5. Machado C.M., Boas L.S., Canto C.L., Andrade Junior H.F., Castelli J., Bohringer P., et al. Disseminated toxoplasmosis after BMT-report of a case. Bone Marrow Transplant 1992, 10(5):475-478.
6. Fayer R., Dubey J.P., Lindsay D.S. Zoonotic protozoa: from land to sea. Trends Parasitol 2004, 20:531-536.
7. Dubey J.P., Hill D.E., Jones J.L., Hightower A.W., Kirkland E., Roberts J.M., et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol 2005, 91(5):1082-1093.
8. Roberts A., Hedman K., Luyasu V., Zufferey J., Bessières M.H., Blatz R.M., et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 2001, 20(7):467-474.
9. Alarcon J.B., Waine G.W., McManus D.P. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv Parasitol 1999, 42:343-410.
10. Blake D.P., Billington K.J., Copestake S.L., Oakes R.D., Quail M.A. Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite. PLoS Pathog 2011, 7(2):e1001279.
11. Zhang H.S., Muller K.A., Compaore Eung-goo L., Liao M., Zhang G.H., Chihiro S., et al. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites. Mol Biochem Parasitol 2007, 151:205-212.
12. Liao M., Xuan X., Huang X., Shirafuji H., Fukumoto S., Hirata H., et al. Identification and characterization of cross-reactive antigens from Neospora caninum and Toxoplasma gondii. Parasitology 2005, 30:481-488.
13. Fernandez C.A., Sanchez V.R., Ledesma B., Frank F.M., Goldman A., Angel S.O., et al. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis. Vaccine 2008, 26:5040-5045.
14. Bounous D.I., Campagnoli R.P., Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 1992, 36(4):1022-1027.
15. Shang L., Liu Q., Liu W., Men J., Gao S., Jiang L., et al. Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge. Vaccine 2009, 27:2741-2745.
16. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003, 21:1327-1335.
17. Liu Q., Shang L., Jin H., Wei F., Zhu X.Q., Gao H. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Res Vet Sci 2010, 89:93-97.
18. Wang H., He S., Yao Y., Cong H., Zhao H., Li T., et al. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Exp Parasitol 2009, 122:226-232.
19. Lau Y.L., Fong M.Y. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris. Exp Parasitol 2008, 119:373-378.
20. Lourenco E.V., Bernardes E.S., Silva N.M., Mineo J.R., Panunto-Castelo A., Roque-Barreira M.C. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes Infect 2006, 8:1244-1251.
21. Fang R., Nie H., Wang Z.S., Tu P., Zhou D., Wang L.X., et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol 2009, 164:134-140.
22. Ismael A.B., Sekkai D., Collin C., Bout D., Mévélec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003, 71(11):6222-6228.
23. Peng G.H., Yuan Z.G., Zhou D.H., He X.H., Liu M.M., Yan C., et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009, 27:6570-6574.
24. Liu M.M., Yuan Z.G., Peng G.H., Zhou D.H., He X.H., Yan C., et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 2010, 106:1079-1084.
25. Yan H.K., Yuan Z.G., Petersen E., Zhang X.X., Zhou D.H., Lin R.Q., et al. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol 2011, 128:38-43.
26. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., et al. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 2007, 56(4):263-268.
27. Leyva R., Hérion P., Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res 2011, 87:70-79.
28. Xue M., He S., Cui Y., Yao Y., Wang H. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitol Int 2008, 57:424-429.
29. Yuan Z.G., Zhang X.X., He X.H., Petersen E., Zhou D.H., He Y., et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 (ROP16) against toxoplasmosis in mice. Clin Vac Immunol 2011, 18:119-124.
30. Yuan Z.G., Zhang X.X., Lin R.Q., Petersen E., He S., Yu M., et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011, 29(38):6614-6619.
31. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 2000, 68:38-45.
32. Jongert E., de Craeye S., Dewit J., Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 2007, 29:445-453.
33. Jongert E., Melkebeek V., De Craeye S., Dewit J., Verhelst D., Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 2008, 26:1025-1031.
34. Desolme B., Mevelec M.N., Dominique B.G., Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 2000, 18:2512-2521.